In 2009, Beck Jr et al. (2009) first identified circulating autoantibodies against phospholipase A2 receptor (PLA2R) in 70% of patients with idiopathic membranous nephropathy (IMN). This evidence concerns the gene PLA2R1 and idiopathic membranous glomerulonephritis.